SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Insecticides (India) moves up on launching future-ready insecticide ‘Granuvia’

18 May 2026 Evaluate

Insecticides (India) is currently trading at Rs. 725.80, up by 5.25 points or 0.73% from its previous closing of Rs. 720.55 on the BSE.

The scrip opened at Rs. 711.80 and has touched a high and low of Rs. 725.80 and Rs. 708.15 respectively. So far 651 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1096.30 on 31-Jul-2025 and a 52 week low of Rs. 525.90 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 730.95 and Rs. 693.60 respectively. The current market cap of the company is Rs. 2088.64 crore.

The promoters holding in the company stood at 72.30%, while Institutions and Non-Institutions held 13.75% and 13.96% respectively.

Insecticides (India) has launched Granuvia, a next-generation, future-ready insecticide in India. Granuvia is designed to provide long-duration control of brown plant hopper (BPH) up to 60 days from days of application, recommended application window 30-35 Days after transplanting, along with up to two weeks of protection against stem borer (for dead heart management) - two of the most damaging pests affecting paddy crop.

Insecticides (India) is engaged in the manufacturing activities of agro chemicals, pesticides and technical products for agriculture purposes.

Insecticides India Share Price

704.80 -21.95 (-3.02%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 611.00
PI Industries 2806.35
Bayer CropScience 4300.70
Sharda Cropchem 906.25
Sumitomo Chemical 457.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×